QQQ   440.36 (+0.31%)
AAPL   179.58 (-0.65%)
MSFT   412.46 (-0.29%)
META   500.00 (+2.01%)
GOOGL   138.00 (-0.33%)
AMZN   176.74 (-0.01%)
TSLA   199.48 (-1.19%)
NVDA   801.76 (+1.34%)
NIO   5.71 (-0.70%)
AMD   195.87 (+1.73%)
BABA   74.82 (+1.07%)
T   16.95 (+0.12%)
F   12.48 (+0.32%)
MU   93.72 (+3.43%)
CGC   3.22 (-2.13%)
GE   158.22 (+0.85%)
DIS   111.40 (-0.16%)
AMC   4.34 (+0.46%)
PFE   26.69 (+0.49%)
PYPL   60.57 (+0.38%)
XOM   106.09 (+1.50%)
QQQ   440.36 (+0.31%)
AAPL   179.58 (-0.65%)
MSFT   412.46 (-0.29%)
META   500.00 (+2.01%)
GOOGL   138.00 (-0.33%)
AMZN   176.74 (-0.01%)
TSLA   199.48 (-1.19%)
NVDA   801.76 (+1.34%)
NIO   5.71 (-0.70%)
AMD   195.87 (+1.73%)
BABA   74.82 (+1.07%)
T   16.95 (+0.12%)
F   12.48 (+0.32%)
MU   93.72 (+3.43%)
CGC   3.22 (-2.13%)
GE   158.22 (+0.85%)
DIS   111.40 (-0.16%)
AMC   4.34 (+0.46%)
PFE   26.69 (+0.49%)
PYPL   60.57 (+0.38%)
XOM   106.09 (+1.50%)
QQQ   440.36 (+0.31%)
AAPL   179.58 (-0.65%)
MSFT   412.46 (-0.29%)
META   500.00 (+2.01%)
GOOGL   138.00 (-0.33%)
AMZN   176.74 (-0.01%)
TSLA   199.48 (-1.19%)
NVDA   801.76 (+1.34%)
NIO   5.71 (-0.70%)
AMD   195.87 (+1.73%)
BABA   74.82 (+1.07%)
T   16.95 (+0.12%)
F   12.48 (+0.32%)
MU   93.72 (+3.43%)
CGC   3.22 (-2.13%)
GE   158.22 (+0.85%)
DIS   111.40 (-0.16%)
AMC   4.34 (+0.46%)
PFE   26.69 (+0.49%)
PYPL   60.57 (+0.38%)
XOM   106.09 (+1.50%)
QQQ   440.36 (+0.31%)
AAPL   179.58 (-0.65%)
MSFT   412.46 (-0.29%)
META   500.00 (+2.01%)
GOOGL   138.00 (-0.33%)
AMZN   176.74 (-0.01%)
TSLA   199.48 (-1.19%)
NVDA   801.76 (+1.34%)
NIO   5.71 (-0.70%)
AMD   195.87 (+1.73%)
BABA   74.82 (+1.07%)
T   16.95 (+0.12%)
F   12.48 (+0.32%)
MU   93.72 (+3.43%)
CGC   3.22 (-2.13%)
GE   158.22 (+0.85%)
DIS   111.40 (-0.16%)
AMC   4.34 (+0.46%)
PFE   26.69 (+0.49%)
PYPL   60.57 (+0.38%)
XOM   106.09 (+1.50%)

Humacyte (HUMAW) Competitors

$0.60
-0.26 (-30.62%)
(As of 09:51 AM ET)

HUMAW vs. ATNFW, SXTPW, DRTSW, APLMW, ARTLW, BCDAW, BCTXW, CDIOW, CTCXW, and SAVAW

Should you be buying Humacyte stock or one of its competitors? The main competitors of Humacyte include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), Artelo Biosciences (ARTLW), BioCardia (BCDAW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), and Cassava Sciences (SAVAW). These companies are all part of the "biotechnology" industry.

Humacyte vs.

180 Life Sciences (NASDAQ:ATNFW) and Humacyte (NASDAQ:HUMAW) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, community ranking, media sentiment, profitability, risk, institutional ownership and analyst recommendations.

180 Life Sciences and Humacyte both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
HumacyteN/AN/A

In the previous week, 180 Life Sciences had 1 more articles in the media than Humacyte. MarketBeat recorded 3 mentions for 180 Life Sciences and 2 mentions for Humacyte. 180 Life Sciences' average media sentiment score of 0.43 beat Humacyte's score of 0.30 indicating that Humacyte is being referred to more favorably in the news media.

Company Overall Sentiment
180 Life Sciences Neutral
Humacyte Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
180 Life Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Humacyte
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Humacyte N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
HumacyteN/AN/AN/AN/AN/A

Summary

180 Life Sciences and Humacyte tied by winning 1 of the 2 factors compared between the two stocks.


Get Humacyte News Delivered to You Automatically

Sign up to receive the latest news and ratings for HUMAW and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HUMAW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HUMAW vs. The Competition

MetricHumacyteBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$273.49M$4.97B$7.50B
Dividend YieldN/A3.47%2.87%3.88%
P/E RatioN/A240.56183.2613.66
Price / SalesN/A22,401.442,943.31171.36
Price / CashN/A11.5496.0354.94
Price / BookN/A5.354.464.66
Net IncomeN/A-$21.81M$114.21M$211.48M
7 Day Performance1.75%-0.06%4.26%2.63%
1 Month Performance89.03%4.45%8.76%5.46%
1 Year Performance57.26%68.24%12.16%8.67%

Humacyte Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATNFW
180 Life Sciences
0 of 5 stars
$0.01
flat
N/A-79.4%$0.00N/A0.005Short Interest ↑
Gap Down
SXTPW
60 Degrees Pharmaceuticals
0 of 5 stars
$0.13
flat
N/AN/A$0.00$90,718.000.002Gap Down
DRTSW
Alpha Tau Medical
0 of 5 stars
$0.28
flat
N/A-37.5%$0.00N/A0.0094Short Interest ↑
News Coverage
Gap Down
APLMW
Apollomics
0 of 5 stars
$0.04
+33.4%
N/AN/A$0.00N/A0.0059Short Interest ↑
Gap Up
ARTLW
Artelo Biosciences
0 of 5 stars
$0.01
flat
N/AN/A$0.00N/A0.005
BCDAW
BioCardia
0 of 5 stars
$0.02
flat
N/AN/A$0.00$570,000.000.0030High Trading Volume
BCTXW
BriaCell Therapeutics
0 of 5 stars
$1.64
+11.6%
N/A-39.5%$0.00N/A0.0016Short Interest ↑
Positive News
CDIOW
Cardio Diagnostics
0 of 5 stars
$0.13
flat
N/A-1.7%$0.00$12,705.000.007Short Interest ↓
Gap Up
CTCXW
Carmell
0 of 5 stars
$0.15
-6.3%
N/AN/A$0.00$3.73M0.009Gap Up
High Trading Volume
SAVAW
Cassava Sciences
0 of 5 stars
$5.92
+25.7%
N/AN/A$0.00N/A0.0026Gap Down

Related Companies and Tools

This page (NASDAQ:HUMAW) was last updated on 3/1/2024 by MarketBeat.com Staff